JPMorgan (AMJB) updates Meta-linked callable notes with 13.50% interest

Rhea-AI Filing Summary

JPMorgan Chase Financial Company LLC amended the pricing terms for its Auto Callable Contingent Interest Notes linked to Meta Platforms, Inc. common stock, due January 4, 2029, which are fully and unconditionally guaranteed by JPMorgan Chase & Co.

The amendment sets a Contingent Interest Rate of 13.50% per annum (3.375% per quarter) and specifies quarterly Contingent Interest Payments of $33.75 per $1,000 principal when the Reference Stock closing price on a Review Date is at or above the Interest Barrier. If the Review Date closing price is below the Interest Barrier, no Contingent Interest Payment will be made for that period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 07:50 PM Learn about SEC filing dates

FAQ

What Contingent Interest Rate is set for the AMJB-linked notes?

The amendment sets a Contingent Interest Rate of 13.50% per annum, payable quarterly at 3.375%. Payments occur only if the Reference Stock closes at or above the Interest Barrier on a Review Date.

How much is the quarterly contingent interest payment per note?

For each $1,000 principal note you receive $33.75 per quarter when the Review Date closing price meets the Interest Barrier. If the closing price is below the Interest Barrier, no payment is made for that Review Date.

Who guarantees these structured notes linked to Meta Platforms?

The notes are fully and unconditionally guaranteed by JPMorgan Chase & Co. The issuing entity is JPMorgan Chase Financial Company LLC, which offers the notes under the referenced prospectus documents.

Are these notes insured or bank deposits?

No. The notes are not bank deposits, are not insured by the FDIC or any government agency, and are not obligations of any bank. Investors should review the listed Risk Factors in the accompanying prospectus materials.

Where can I find the full terms and risk factors for these notes?

The amendment refers to the pricing supplement, product supplement, prospectus supplement, prospectus, and prospectus addendum; links to each document are provided in the amendment for full terms and Risk Factors.

February 17, 2026 Registration Statement Nos. 333-270004 and 333-270004-01; Rule 424(b)(3)
Amendment no. 1 to pricing supplement dated January 15, 2026 to product supplement no. 4-I dated April 13, 2023, the prospectus and prospectus
supplement, each dated April 13, 2023,
and the prospectus addendum dated June 3, 2024
JPMorgan Chase Financial Company LLC
Structured Investments
Auto Callable Contingent Interest Notes Linked to the Class A
Common Stock of Meta Platforms, Inc. due January 4, 2029
Fully and Unconditionally Guaranteed by JPMorgan Chase & Co.
Notwithstanding anything to the contrary set forth in the pricing supplement dated January 15, 2026, related to the notes referred to
above (the “pricing supplement”), the Contingent Interest Payments and the Contingent Interest Rate are as set forth below:
Contingent Interest Payments: If the notes have not been automatically called and the closing price of one share of the Reference
Stock on any Review Date is greater than or equal to the Interest Barrier, you will receive on the applicable Interest Payment Date for
each $1,000 principal amount note a Contingent Interest Payment equal to $33.75 (equivalent to a Contingent Interest Rate of 13.50%
per annum, payable at a rate of 3.375% per quarter)
If the closing price of one share of the Reference Stock on any Review Date is less than the Interest Barrier, no Contingent Interest
Payment will be made with respect to that Review Date.
Contingent Interest Rate: 13.50% per annum, payable at a rate of 3.375% per quarter
CUSIP: 48136M5D5
Investing in the notes involves a number of risks. See “Risk Factors” beginning on page S-2 of the accompanying
prospectus supplement, Annex A to the accompanying prospectus addendum, “Risk Factors” beginning on page PS-11 of the
accompanying product supplement and “Selected Risk Considerations” beginning on page PS-4 of the pricing supplement.
Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of the
notes or passed upon the accuracy or the adequacy of this amendment, the pricing supplement or the accompanying product
supplement, prospectus supplement, prospectus and prospectus addendum. Any representation to the contrary is a criminal offense.
The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and
are not obligations of, or guaranteed by, a bank.
You should read this amendment together with the pricing supplement and the related product supplement, prospectus supplement and
prospectus and prospectus addendum, each of which can be accessed via the hyperlinks below. Please also see “Additional Terms
Specific to the Notes” in the pricing supplement.
• Pricing supplement dated January 15, 2026:
http://www.sec.gov/Archives/edgar/data/19617/000191870426001133/form424b2.htm
• Product supplement no. 4-I dated April 13, 2023:
http://www.sec.gov/Archives/edgar/data/19617/000121390023029539/ea152803_424b2.pdf
• Prospectus supplement and prospectus, each dated April 13, 2023:
http://www.sec.gov/Archives/edgar/data/19617/000095010323005751/crt_dp192097-424b2.pdf
• Prospectus addendum dated June 3, 2024:
http://www.sec.gov/Archives/edgar/data/1665650/000095010324007599/dp211753_424b3.htm